Elotuzumab enhances the anti-tumor activity of Vγ9Vδ2 T cells against primary effusion lymphoma

European Journal of Pharmacology 2026

View at publisher

Authors: Kosuke Maeda, Ryusho Kariya, Jutatip Panaampon, Keishi Matsuda, Seiji Okada

DOI: 10.1016/j.ejphar.2026.178922

Cited by: 0

References: 62

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research

References 62